Viewing StudyNCT00221624

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00221624
Status: COMPLETED
Last Update Posted: 2007-06-13
First Post: 2005-09-13
Brief Title: Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
Sponsor: University Hospital Bordeaux
Organization: University Hospital Bordeaux
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Hepatitis C Chronic
HCV Infection
Keywords:
Name View
Drug Therapy Combination View
Hepatitis C chronic View
HCV infection View
Treatment failure View
PEG Interferon View
Interferonstherapeutic use View
Interferon Alfa-2aadverse effects View
ribavirin View
Ribavirintherapeutic use View
Ribavirinadverse effects View
Amantadine View